Alpha 2.0
Login Register
» Articles » PMID: 21570775

WITHDRAWN: Bisphosphonates Promote Jaw Osteonecrosis Through Facilitating Bacterial Colonisation

Overview
Journal Med Hypotheses
Specialty General Medicine
Date 2011 May 17
PMID 21570775
Citations 13
Authors
M Kos
Affiliations
Soon will be listed here.
Citing Articles

Bisphosphonate-Related Osteonecrosis of the Jaw and Oral Microbiome: Clinical Risk Factors, Pathophysiology and Treatment Options.

Jelin-Uhlig S, Weigel M, Ott B, Imirzalioglu C, Howaldt H, Bottger S Int J Mol Sci. 2024; 25(15).

PMID: 39125621 PMC: 11311822. DOI: 10.3390/ijms25158053.

Can medication-related osteonecrosis of the jaw be attributed to specific microorganisms through oral microbiota analyses? A preliminary study.

Kim H, Jung Y, Park W, Choi Y, Kim J BMC Oral Health. 2024; 24(1):160.

PMID: 38302952 PMC: 10832156. DOI: 10.1186/s12903-024-03945-z.

Natural Products from Chinese Medicines with Potential Benefits to Bone Health.

Che C, Wong M, Kei Lam C Molecules. 2016; 21(3):239.

PMID: 26927052 PMC: 6274145. DOI: 10.3390/molecules21030239.

Incidence and risk predictors for osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates.

Kos M Arch Med Sci. 2015; 11(2):319-24.

PMID: 25995747 PMC: 4424249. DOI: 10.5114/aoms.2015.50964.

Oral microbiota and host innate immune response in bisphosphonate-related osteonecrosis of the jaw.

Pushalkar S, Li X, Kurago Z, Ramanathapuram L, Matsumura S, Fleisher K Int J Oral Sci. 2014; 6(4):219-26.

PMID: 25105817 PMC: 5153588. DOI: 10.1038/ijos.2014.46.